Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation

<b>Background</b>: Gegen Qinlian Decoction (GQD), is used for intestinal disorders like ulcerative colitis, irritable bowel syndrome, and colorectal cancer. But the precise mechanisms underlying its anti-inflammatory and anti-tumor effects are not fully elucidated. <b>Methods</b...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yaoyao Xu, Qiaoyan Cai, Chunyu Zhao, Weixiang Zhang, Xinting Xu, Haowei Lin, Yuxing Lin, Daxin Chen, Shan Lin, Peizhi Jia, Meiling Wang, Ling Zhang, Wei Lin
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Pharmaceuticals
Subjects:	Gegen Qinlian Decoction colitis-associated colorectal cancer azoxymethane/dextran sodium sulfate inflammatory response network pharmacology TLR4 signaling pathway
Online Access:	https://www.mdpi.com/1424-8247/18/1/12
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation

Similar Items